CN Stock MarketDetailed Quotes

Tiansheng Pharmaceutical Group (002872)

Watchlist
  • 5.14
  • +0.12+2.39%
Market Closed Jun 12 15:00 CST
1.63BMarket Cap-30.96P/E (TTM)

Tiansheng Pharmaceutical Group (002872) Revenue Breakdown Overview

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
Self-made oral solid preparation234.69M45.65%
Self-made small volume injection120.3M23.40%
Homemade large volume injection84.22M16.38%
Other business40.96M7.97%
Outsourcing variety17.15M3.34%
Homemade other varieties16.76M3.26%
View all

By Industry

Currency:CNY
2025/FY
Stock NameRevenueRatio
Pharmaceutical manufacturing455.98M88.70%
Other business40.96M7.97%
Pharmaceutical circulation17.15M3.34%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
Southwest area235.9M45.89%
East China region80.63M15.68%
South China72.74M14.15%
Central China72.36M14.07%
Northwest region23.74M4.62%
North China20.36M3.96%
Northeast area8.36M1.63%
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
The U.S.-Iran peace talks have entered a critical window! On the 14th, Iranian sources indicated that Pakistan will host a video conference Show More